Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Avid Bioservices, Inc. (CDMO)

15.58   0.13 (0.84%) 06-01 16:00
Open: 15.45 Pre. Close: 15.45
High: 15.86 Low: 15.14
Volume: 292,240 Market Cap: 974(M)

Technical analysis

as of: 2023-06-01 4:43:20 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 19.95     One year: 22.02
Support: Support1: 14.21    Support2: 11.82
Resistance: Resistance1: 17.08    Resistance2: 18.86
Pivot: 15.95
Moving Average: MA(5): 15.27     MA(20): 16.53
MA(100): 17.09     MA(250): 16.64
MACD: MACD(12,26): -0.9     Signal(9): -0.8
Stochastic oscillator: %K(14,3): 25.6     %D(3): 22.3
RSI: RSI(14): 39.6
52-week: High: 21.04  Low: 11.34
Average Vol(K): 3-Month: 606 (K)  10-Days: 554 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CDMO ] has closed above bottom band by 42.1%. Bollinger Bands are 46.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.87 - 15.94 15.94 - 16.01
Low: 14.98 - 15.04 15.04 - 15.12
Close: 15.46 - 15.56 15.56 - 15.68

Company Description

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Headline News

Thu, 01 Jun 2023
A Look at Avid Bioservices Inc. (CDMO) Shares in the Recent Past ... - SETE News

Wed, 31 May 2023
Principal Financial Group Inc. Increases Holdings in Avid ... - Best Stocks

Wed, 31 May 2023
Principal Financial Group Inc. Raises Holdings in Avid Bioservices ... - MarketBeat

Tue, 30 May 2023
Viral Vector Manufacturing Global Market is Predicted to Exhibit ... - GlobeNewswire

Sun, 21 May 2023
Little Excitement Around Avid Bioservices, Inc.'s (NASDAQ:CDMO) Earnings As Shares Take 26% Pounding - Simply Wall St

Thu, 11 May 2023
Laughing Water Capital Q1 2023 Letter - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 63 (M)
Shares Float 58 (M)
% Held by Insiders 0.6 (%)
% Held by Institutions 109.1 (%)
Shares Short 5,260 (K)
Shares Short P.Month 4,990 (K)

Stock Financials

EPS 1.67
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.96
Profit Margin (%) 82.7
Operating Margin (%) 2.7
Return on Assets (ttm) 0.6
Return on Equity (ttm) 96.2
Qtrly Rev. Growth 20.7
Gross Profit (p.s.) 0.58
Sales Per Share 2.24
EBITDA (p.s.) 0.16
Qtrly Earnings Growth -79.7
Operating Cash Flow -15 (M)
Levered Free Cash Flow -68 (M)

Stock Valuations

PE Ratio 9.27
PEG Ratio 97.2
Price to Book value 5.26
Price to Sales 6.92
Price to Cash Flow -64.67

Stock Dividends

Dividend 0.66
Forward Dividend 0
Dividend Yield 4.2%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.